Zoetis Inc. (ZTS): Net Income
$2.67B
Year ended 2025-12-31
+8.1%
3-year compound annual growth
+10.3%
5-year compound annual growth
+22.9%
10-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.67B | +7.5% | 2026-02-12, From 2025-01-01 |
| 2024-12-31 | $2.49B | +6.1% | 2026-02-12, From 2024-01-01 |
| 2023-12-31 | $2.34B | +10.9% | 2026-02-12, From 2023-01-01 |
| 2022-12-31 | $2.11B | +3.8% | 2025-02-13, From 2022-01-01 |
| 2021-12-31 | $2.04B | +24.4% | 2024-02-13, From 2021-01-01 |
| 2020-12-31 | $1.64B | +9.2% | 2023-02-14, From 2020-01-01 |
| 2019-12-31 | $1.50B | +5.0% | 2022-02-15, From 2019-01-01 |
| 2018-12-31 | $1.43B | +65.3% | 2021-02-16, From 2018-01-01 |
| 2017-12-31 | $864.00M | +5.2% | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | $821.00M | +142.2% | 2019-02-14, From 2016-01-01 |
| 2015-12-31 | $339.00M | -41.9% | 2018-02-15, From 2015-01-01 |
| 2014-12-31 | $583.00M | +15.7% | 2017-02-16, From 2014-01-01 |
| 2013-12-31 | $504.00M | +15.6% | 2016-02-24, From 2013-01-01 |
| 2012-12-31 | $436.00M | +78.0% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $245.00M | n/a | 2014-03-26, From 2011-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Zoetis Inc. (ZTS) | 2025-12-31 | $2.67B | +7.5% |
| Bausch Health Companies Inc. (BHC) | 2025-12-31 | $120.00M | n/m |
| Vertex Pharmaceuticals Inc (VRTX) | 2025-12-31 | $3.95B | n/m |
| Viatris Inc (VTRS) | 2025-12-31 | -$3.51B | n/m |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $4.50B | +2.1% |
| Organon & Co. (OGN) | 2025-12-31 | $187.00M | -78.4% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $286.93M | n/m |
| Teva Pharmaceutical Industries Ltd (TEVA) | 2025-12-31 | $1.41B | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$232.00M | n/m |
Compare ZTS, BHC, VRTX, VTRS side by side · Screen every company in Pharmaceutical Preparations ↗